Coindar brings you the latest news that Eric Chen, the co-founder of Injective Protocol, is all set to grace the stage at the highly anticipated Digital Asset Summit in New York. The event is scheduled to be held from March 18th to 20th.
Chen will share insights on how Injective is pioneering advancements in areas such as tokenization, blockchain-based stocks, and the amalgamation of traditional and decentralized finance, heralding a fresh epoch of finance.
Here is the official tweet from INJ:
Injective 🥷
@injective
Injective co-founder @ericinjective will be speaking at The Digital Asset Summit next week!
Get a glimpse of how Injective is spearheading the journey towards tokenization, on-chain stocks, and the fusion of TradFi and DeFi, giving rise to a new financial era.
Dated: Mar 15, 2025
Injective Protocol, a decentralized exchange (DEX) protocol constructed on the Cosmos SDK, offers advanced cross-chain trading options. Here are some key features of Injective Protocol:
- Decentralization: The Injective platform empowers users with complete control over their funds, without any third-party involvement.
- Cross-chain trading: Injective enables trading across different blockchains, offering users a plethora of tradable assets.
- High performance: Thanks to the Tendermint consensus system, Injective promises high throughput and minimal transaction latency.
- Gas-free transactions: Users can trade without the compulsion of paying gas fees.
The native token of Injective Protocol is INJ, which is employed for protocol governance, staking, and participating in voting processes crucial to protocol upgrades and management decisions.
Stay tuned with Coindar for more crypto updates!
